Guangzhou Institutes of Biomedicine and Health, Chinese Academyof Sciences (GlBH) was jointly established by Chinese Academy ofSciences (CAS), the People's Government of Guangdong Province andthe People's Government of Guangzhou Municipality after the SARSoutbreak in 2003 and was ofhcially founded in March 2006. lt is thehrst research institute of CAS that focuses on local economic andsocial development and manifests CAS's cooperation with the localgovernment. The establishment of GlBH has compensated the lackingof a national biomedicine research institute in South China, and hasbeen regarded as a successful example in the exploration of buildingnew R&D institute in China.

Aimed to achieve the goal of "Healthy China" strategy and satisfy human health demands, GIBH is exploring disease mechanism with the cutting-edge technologies and developing innovative protocols for disease control and prevention. It provides excellent R&D platform in biomedicine and functions as an incubator for bioengineering and pharmaceutical industries to support local economic development as well as national strategic science and technology programs.

University of Chinese Academy of Sciences was established with the approval of Ministry of Education of the People’s Republic of China (PRC). Its predecessor, Graduate University of Chinese Academy of Sciences (GUCAS), was the first graduate school in China. UCAS graduated the PRC’s first doctoral student in science, first doctoral student in engineering, first female doctoral student, and first student with double doctoral degrees. In June 2012, GUCAS was renamed UCAS.